Publications 2018

Huang QF, Zhang ZY, Van Keer J, Trenson S, Nkuipou-Kenfack E, Yang WY, Thijs L, Vanhaecke J, Van Aelst LNL, Van Cleemput J, Janssens S, Verhamme P, Mischak H, Staessen JA.

Urinary peptidomic biomarkers of renal function in heart transplant recipients.

Nephrol Dial Transplant. 2018 Jul 2. doi: 10.1093/ndt/gfy185. [Epub ahead of print]

PMID: 29982668

View Abstract:   Request Reprint



Belczacka I, Latosinska A, Metzger J, Marx D, Vlahou A, Mischak H, Frantzi M.

Proteomics biomarkers for solid tumors: Current status and future prospects.

Mass Spectrom Rev. 2018 Jun 11. doi: 10.1002/mas.21572. [Epub ahead of print] Review.

PMID: 29889308

View Abstract:  Request Reprint


Huang QF, Trenson S, Zhang ZY, Van Keer J, Van Aelst LNL, Yang WY, Nkuipou-Kenfack E, Thijs L, Wei FF, Mujaj B, Ciarka A, Droogné W, Vanhaecke J, Janssens S, Van Cleemput J, Mischak H, Staessen JA.

Biomarkers to Assess Right Heart Pressures in Recipients of a Heart Transplant: A Proof-of-Concept Study.

Transplant Direct. 2018 Apr 23;4(5):e346. doi: 10.1097/TXD.0000000000000783. eCollection 2018 May.

PMID: 29796417

View Abstract:  Request Reprint


Frantzi M, Latosinska A, Kontostathi G, Mischak H.

Clinical Proteomics: Closing the Gap from Discovery to Implementation.

Proteomics. 2018 Jul;18(14):e1700463. doi: 10.1002/pmic.201700463. Epub 2018 Jul 8.

PMID: 29785737

View Abstract:  Request Reprint


Tofte N, Lindhardt M, Adamova K, Beige J, Beulens JWJ, Birkenfeld AL, Currie G, Delles C, Dimos I, Francová L, Frimodt-Møller M, Girman P, Göke R, Havrdova T, Kooy A, Mischak H, Navis G, Nijpels G, Noutsou M, Ortiz A, Parvanova A, Persson F, Ruggenenti PL, Rutters F, Rychlík I, Spasovski G, Speeckaert M, Trillini M, von der Leyen H, Rossing P.

Characteristics of high- and low-risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes.

Diabet Med. 2018 May 21. doi: 10.1111/dme.13669. [Epub ahead of print]

PMID: 29781558

View Abstract:  Request Reprint


Zhang ZY, Nkuipou-Kenfack E, Yang WY, Wei FF, Cauwenberghs N, Thijs L, Huang QF, Feng YM, Schanstra JP, Kuznetsova T, Voigt JU, Verhamme P, Mischak H, Staessen JA.

Epidemiologic observations guiding clinical application of a urinary peptidomic marker of diastolic left ventricular dysfunction.

J Am Soc Hypertens. 2018 Jun;12(6):438-447.e4. doi: 10.1016/j.jash.2018.03.007. Epub 2018 Mar 21.

PMID: 29681522

View Abstract:  Request Reprint


Pejchinovski M, Mischak H.

Clinical Proteomics in Kidney Disease: From Discovery to Clinical Application.

Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2017 Dec 1;38(3):39-54. doi: 10.2478/prilozi-2018-0005.

PMID: 29668468

View Abstract:  Request Reprint


Lygirou V, Latosinska A, Makridakis M, Mullen W, Delles C, Schanstra JP, Zoidakis J, Pieske B, Mischak H, Vlahou A.

Plasma proteomic analysis reveals altered protein abundances in cardiovascular disease.

J Transl Med. 2018 Apr 17;16(1):104. doi: 10.1186/s12967-018-1476-9.

PMID: 29665821

View Abstract:  Request Reprint


Currie GE, von Scholten BJ, Mary S, Flores Guerrero JL, Lindhardt M, Reinhard H, Jacobsen PK, Mullen W, Parving HH, Mischak H, Rossing P, Delles C.

Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria.

Cardiovasc Diabetol. 2018 Apr 6;17(1):50. doi: 10.1186/s12933-018-0697-9.

PMID: 29625564

View Abstract:  Request Reprint


Liu Y, Pejchinovski M, Wang X, Fu X, Castelletti D, Watnick TJ, Arcaro A, Siwy J, Mullen W, Mischak H, Serra AL.

Dual mTOR/PI3K inhibition limits PI3K-dependent pathways activated upon mTOR inhibition in autosomal dominant polycystic kidney disease.

Sci Rep. 2018 Apr 3;8(1):5584. doi: 10.1038/s41598-018-22938-x.

PMID: 29615724

View Abstract:  Request Reprint


Magalhães P, Pontillo C, Pejchinovski M, Siwy J, Krochmal M, Makridakis M, Carrick E, Klein J, Mullen W, Jankowski J, Vlahou A, Mischak H, Schanstra JP, Zürbig P, Pape L.

Comparison of Urine and Plasma Peptidome Indicates Selectivity in Renal Peptide Handling.

Proteomics Clin Appl. 2018 Apr 3:e1700163. doi: 10.1002/prca.201700163. [Epub ahead of print]

PMID: 29611317

View Abstract:  Request Reprint


Belczacka I, Latosinska A, Siwy J, Metzger J, Merseburger AS, Mischak H, Vlahou A, Frantzi M, Jankowski V.

Urinary CE-MS peptide marker pattern for detection of solid tumors.

Sci Rep. 2018 Mar 27;8(1):5227. doi: 10.1038/s41598-018-23585-y. [Epub ahead of print]

PMID: 29588543

View Abstract:  Request Reprint


Marx D, Metzger J, Pejchinovski M, Gil RB, Frantzi M, Latosinska A, Belczacka I, Heinzmann SS, Husi H, Zoidakis J, Klingele M, Herget-Rosenthal S.

Urinary CE-MS peptide marker pattern for detection of solid tumors.

Semin Nephrol. 2018 Jan;38(1):63-87. doi: 10.1016/j.semnephrol.2017.09.007. Review.

PMID: 29291763

View Abstract:  Request Reprint


Duranton F, Laget J, Gayrard N, Saulnier-Blache JS, Lundin U, Schanstra JP, Mischak H, Weinberger KM, Servel MF, Argilés A.                  

The CKD plasma lipidome varies with disease severity and outcome.                                                                                                    

J Clin Lipidol. 2018 Aug 1. pii: S1933-2874(18)30350-7. doi: 10.1016/j.jacl.2018.07.010. [Epub ahead of print]

PMID: 30177483

View Abstract:  Request Reprint


Latosinska A., Frantzi M., Merseburger AS, Mischak H,

Promise and Implementation of Proteomic Prostate Cancer Biomarkers.

Diagnostics (Basel). 2018 Aug 29:8(3). pii: E57. doi: 10.3390/diagnostics8030057. Review

PMID: 30158500

View Abstract:  Request Reprint